Tech Company Financing Transactions
ApoCell Funding Round
On 9/30/2009, ApoCell secured financing from Summit Partners.
Transaction Overview
Company Name
Announced On
9/30/2009
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Summit Partners (Thomas Jennings)
Proceeds Purpose
The investment will be used to fund ApoCell's organic growth initiatives and continued development of the company's state-of-the-arttechnology platforms.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2575 West Bellfort Blvd. 190
Houston, TX 77054
USA
Houston, TX 77054
USA
Phone
Website
Email Address
Overview
ApoCell specializes in the isolation and molecular characterization of rare circulating cells from human blood. ApoCell is an industry leader in the field of biomarker research, helping to monitor the mechanisms and effects of drug treatments, moving towards the development of personalized therapies for patients of many disease types.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Controller
Jan Lawler
President
Chad Clark
Vice President
Darren Davis
Vice President
Deborah Phippard
VP - Operations
Joseph Bower
VP - Regulatory Affairs
William Soller
Browse more venture capital transactions:
Prev: 9/30/2009: Primus Power venture capital transaction
Next: 9/30/2009: Vox Spectrum venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs